Does reactivation of cytomegalovirus contribute to severe COVID-19 disease?

47Citations
Citations of this article
110Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The majority of people infected with SARS-CoV-2 are asymptomatic or have mild to moderate symptoms. However, for unknown reasons, about 15 % have severe pneumonia requiring hospital care and oxygen support, and about 5 % develop acute respiratory distress syndrome, septic shock, and multiorgan failure that result in a high mortality rate. The risk of severe COVID-19 is highest among those who are over 70 years of age. Why severe COVID-19 develops in some people but not others is not understood. Could some cases involve reactivation of latent cytomegalovirus (CMV)?

Cite

CITATION STYLE

APA

Söderberg-Nauclér, C. (2021). Does reactivation of cytomegalovirus contribute to severe COVID-19 disease? Immunity and Ageing, 18(1). https://doi.org/10.1186/s12979-021-00218-z

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free